Product combines fish-skin grafts and silicone for optimal wound healing environment.
Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today announced the availability of Shield Standard, which combines a fish-skin graft and silicone backing for efficient treatment of acute and chronic wounds.
Shield Standard is a part of the Kerecis Shield product family, which is designed for managing chronic and acute wounds such as diabetic foot ulcers, pressure ulcers, vascular ulcers, post-Moh’s surgical wounds, and draining wounds. The grafts contain essential natural skin elements and are fenestrated to allow adequate wound drainage for appropriate wound moisture at the wound bed.
“The positive feedback we have received from healthcare professionals for the initial Shield product inspired us to expand the product range.
We’ve seen some remarkable outcomes with Shield Adhesive, and we are committed to filling the demand for greater variety in wound-care solutions.”
– Fertram Sigurjonsson, CEO and founder of Kerecis.
For media inquiries, please contact:
Hrannar Pétursson
Director of Communication
+354 666 1000
hpet@kerecis.com
